<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02981186</url>
  </required_header>
  <id_info>
    <org_study_id>PHY1603</org_study_id>
    <nct_id>NCT02981186</nct_id>
  </id_info>
  <brief_title>Comparison of Visual Outcomes After Implantation of the POD AY GF F (PhysIOL) and the POD AY 26P F (PhysIOL)</brief_title>
  <official_title>Comparison of Visual Outcomes After Implantation of the POD AY GF F (PhysIOL) and the POD AY 26P F (PhysIOL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beaver-Visitec International, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beaver-Visitec International, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective randomised controlled study. The patients get monolateral IOL&#xD;
      implantation of POD F GF and POD F in the contralateral eye. Both IOLs are trifocal IOLs&#xD;
      consisting of the same optical design. The difference between the IOLs is the material&#xD;
      (hydrophilic and hydrophobic).&#xD;
&#xD;
      To decide which eye receives POD F and which eye receives POD F GF, a randomization table&#xD;
      will be provided to the principle investigator.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The examinations consist of visual acuity data, contrast sensitivity exams and slitlamp&#xD;
      examinations.&#xD;
&#xD;
      Follow up will be up to 6 months postoperative.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2, 2016</start_date>
  <completion_date type="Actual">September 25, 2017</completion_date>
  <primary_completion_date type="Actual">September 25, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity at far, near and intermediate distance</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>ability to read letters at different distances</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Cataract</condition>
  <condition>Lens Opacity</condition>
  <arm_group>
    <arm_group_label>IOL Implantation experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of POD F GF in one of the eyes of the study subject</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IOL Implantation Comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation of POD F in the contralateral eye of the study subject</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IOL implantation experimental</intervention_name>
    <description>Implantation of trifocal IOL POD F GF consisting of hydrophobic material</description>
    <arm_group_label>IOL Implantation experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IOL implantation comparator</intervention_name>
    <description>Implantation of trifocal IOL POD F consisting of hydrophilic material</description>
    <arm_group_label>IOL Implantation Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cataractous Eyes with no comorbidity&#xD;
&#xD;
          -  Patient older than 50 years old&#xD;
&#xD;
          -  Regular corneal astigmatism &lt;0.75 dioptres by an automatic keratometer (regularity&#xD;
             determined by the topography of the keratometry) or &lt;1.0 dioptres if the steep axis of&#xD;
             cylinder is between 90° and 120°&#xD;
&#xD;
          -  Spontaneously emitting the desire for spectacle independence after surgery and with&#xD;
             realistic expectation.&#xD;
&#xD;
          -  Availability, willingness and sufficient cognitive awareness to comply with&#xD;
             examination procedures&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unrealistic expectation&#xD;
&#xD;
          -  Irregular astigmatism&#xD;
&#xD;
          -  Difficulty for cooperation (distance from their home, general health condition)&#xD;
&#xD;
          -  Acute or chronic disease or illness that would increase risk or confound study results&#xD;
             (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)&#xD;
&#xD;
          -  Any ocular comorbidity&#xD;
&#xD;
          -  History of ocular trauma or prior ocular surgery including refractive procedures&#xD;
&#xD;
          -  Capsule or zonular abnormalities that may affect postoperative centration or tilt of&#xD;
             the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)&#xD;
&#xD;
          -  Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils&#xD;
             that do not dilate under mesopic/scotopic conditions)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zoltan Nagy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis University - Department of Ophthalmology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Semmelweis University - Department of Ophthalmology</name>
      <address>
        <city>Budapest</city>
        <zip>1085</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>November 29, 2016</study_first_submitted>
  <study_first_submitted_qc>November 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2016</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intraocular Lens</keyword>
  <keyword>trifocal</keyword>
  <keyword>cataract</keyword>
  <keyword>PhysIOL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

